US$ 24.89
compare glp-1 drugs McKee's proposed FY2027 budget drops for weight loss from Medicaid • Rhode Island Current glp 1 medications covered by
Description
Studies suggest side effects can occur in 40-70% of patients receiving a GLP-1 RA

Hirshberg B, Parker A, Edelberg H, Donovan M, Iqbal N

Yet too often, ads minimized risks or promoted unrealistic outcomes

Morton also emphasizes that weight regain is not a personal failure
For example, tirzepatide (sold under the brand name Zepbound) targets two receptors, and clinical trials suggest it helps people lose more weight than semaglutide (the active ingredient in Wegovy), which only targets one

Of those who received Wegovy, 73% lost at least 5% of their starting body weight by the end of the study
